Owaves Accepted into EvoNexus Technology Incubator
ENCINITAS, CA, January 9th, 2026 – Owaves today announced that it has been accepted into EvoNexus, a nonprofit technology incubator supporting early-stage companies through long-term mentorship, strategic partnerships, and investor readiness. Owaves joins the EvoNexus community of Southern California innovators, including alumni such as Carlsmed and Biolinq, advancing companies toward key growth milestones such as scaling revenue, expanding partnerships, and institutional fundraising. EvoNexus is widely recognized for its milestone-driven incubation model and founder-friendly approach.
Supporting the Next Phase of Growth
EvoNexus supports technology startups as they advance product development, secure enterprise partnerships, and raise venture capital. The incubator provides access to experienced mentors, corporate collaborators, and a broad investor network, emphasizing sustainable, long-term growth rather than short-term acceleration. Since 2010, EvoNexus portfolio companies have achieved more than $5.1 billion in funding and outcomes, with an estimated $6 billion in aggregate pre-exit valuation.
“EvoNexus is Southern California’s most respected and competitive incubator,” said Royan Kamyar, M.D., MBA, Founder and CEO of Owaves. “We’re already benefiting from conversations with mentors and fellow portfolio companies. Health technology continues to boom across the region, and we’re excited to be part of that ecosystem.”
For Owaves, participation in EvoNexus comes at a pivotal moment, supporting the company as it scales its subscription product, BodyClock AI™, and sharpens its go-to-market strategy.
Aligned Missions in Health, Science, and Technology
Owaves is a digital health company optimizing circadian rhythms to promote student flourishing. BodyClock AI™ helps students build healthier daily routines by improving time management, sleep regularity, and alignment with biological rhythms.
Today, approximately 1 in 8 young adults lives with ADHD, representing a threefold increase since 2010. At the same time, nearly two-thirds of college students experience significant mental health challenges before graduation, including anxiety, depression, and chronic stress. A growing body of evidence points to circadian disruption, poor sleep quality, and difficulties managing daily routines—often described as “time blindness”—as underlying contributors to these challenges. Chronically irregular schedules and misaligned sleep patterns are associated with lower GPAs, reduced graduation rates, and increased dropout risk. Nearly 40% of college students have recently considered withdrawing from school due to emotional stress and mental health concerns.
Owaves addresses this challenge by empowering students to manage their time more intentionally, realign circadian rhythms, and establish sustainable daily routines—supporting academic performance, mental wellbeing, and overall student success, particularly for individuals coping with ADHD, anxiety, or depression.
Since launch, Owaves has attracted more than 1.3 million organic downloads, been ranked #1 in Health & Fitness on iPad across 135+ countries, and logged over 615 million scheduled activities, creating one of the world’s richest behavioral rhythm datasets. After five years contributing to research initiatives supported by the National Institutes of Health under the Precision Medicine Initiative, Owaves is entering its next phase, scaling a consumer-facing platform that applies evidence-based science to everyday life. The company is pioneering a new category of care it calls precision lifestyle psychiatry, in collaboration with partners at UC San Diego and the Scripps Research Institute.
As demand grows for preventive, non-pharmacological approaches to mental health—particularly among students and young adults—Owaves is expanding partnerships with universities and health-focused organizations. Participation in EvoNexus strengthens the company’s ability to pursue these opportunities while maintaining clinical integrity and growing the business.
Focus Areas During Incubation
Through the EvoNexus incubation program, Owaves will focus on these priorities:
- Scaling BodyClock AI™, including continued development of AI-supported personalization grounded in circadian science
- Building strategic partnerships across healthcare and education to support distribution, scale, and impact
- Advancing investor readiness and fundraising strategy with support from EvoNexus mentors and advisors
Looking Ahead
Owaves begins incubation with EvoNexus this week and is already looking ahead to Demo Day 2027. Through the program, the company will focus on scaling its subscription offerings, strengthening go-to-market execution, and preparing for its first round of institutional financing. Owaves remains committed to its mission of helping college students plan their days in ways that support long-term health, productivity, balance, and well-being.
About Owaves
Owaves is a digital health company optimizing circadian rhythms to promote student flourishing. BodyClock AI™ helps students build healthier daily routines through improved time management, sleep, and rhythm alignment. The platform has attracted more than 1.3 million organic downloads, received over 5,000 five-star reviews, been ranked #1 in Health & Fitness on iPad across 135+ countries, and logged over 615 million activities. Clinical validation partners include UC San Diego and the Scripps Research Institute.
About EvoNexus
EvoNexus is a nonprofit technology incubator supporting early-stage startups through mentorship, workspace, corporate connections, and access to capital. With locations across Southern California, EvoNexus has helped hundreds of companies grow and scale across multiple technology sectors. Since 2010, EvoNexus portfolio companies have achieved more than $5.1 billion in funding and outcomes, with an estimated $6 billion in aggregate pre-exit valuation.